Pharmafile Logo

News and Press Releases

Clinigen appoints Fernando Ballester as Chief Financial Officer

2 July 2024 -- London, UK -- Clinigen, the global pharmaceutical services company, today announces the appointment of Fernando Ballester as chief financial officer (CFO), effective 1 August 2024. Fernando,...

Category: Other, Pharmaceutical
Posted: July 2, 2024

Clinigen
25 Bedford Square Bloomsbury London WC1B 3HH

Clinigen acquires boutique market access consultancy Ascenian to accelerate access to lifesaving treatments

6 June 2024 -- London, UK -- Clinigen, the global pharmaceutical services company, today announces the acquisition of Ascenian, a boutique global market access consultancy. Together the combined companies will...

Category: Other, Pharmaceutical
Posted: June 6, 2024

Clinigen
25 Bedford Square Bloomsbury London WC1B 3HH

Biogen Receives European Commission Approval for QALSODY (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS

SOD1-ALS is a devastating, uniformly fatal and ultra-rare genetic form of ALS estimated to affect less than 1,000 people in Europe QALSODY is Biogen’s third rare disease therapy to be...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: May 30, 2024

Biogen
Biogen International GmbH Neuhofstrasse 30 6340 Baar Switzerland

TMC Pharma champions holistic approach to medical services in rare disease drug development

13 March 2024 – In a recent webinar, rare disease specialist and global clinical research organisation (CRO) TMC Pharma gathered esteemed speakers to share insights into the scope of medical...

Category: Drug Discovery, Pharmaceutical
Posted: March 13, 2024

TMC Pharma
info@tmcpharma.com
Lodge Farm Barn Elvetham Park Estate, Fleet Road, Hartley Wintney, Hampshire RG27 8AS, UK

Clinigen boosts senior team with three strategic hires 

12 March 2024 -- London, UK -- Clinigen, the global pharmaceutical services company, today announces three strategic appointments to advance its transformation into a world leading pharma services company: Nihad...

Category: Other
Posted: March 12, 2024

Clinigen
25 Bedford Square Bloomsbury London WC1B 3HH

Clinigen launches ‘What is Possible?’ campaign to accelerate access to medicines on Rare Disease Day 

With over 7,000 rare diseases that impact over 300 million people globally, just 5% of rare diseases have a licensed treatment 29 February 2024 -- London, UK -- Clinigen, the...

Category: Other
Posted: February 29, 2024

Clinigen
25 Bedford Square Bloomsbury London WC1B 3HH